Morton Capital Management Llc/Ca Pfizer Inc Transaction History

Morton Capital Management Llc/Ca

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 05, 2023	SELL	$32.09 - $37.51 $32,090 - $37,510	-1,000 Reduced 13.96%	6,165 $204 Million
Q2 2023 Dec 05, 2023	SELL	$36.12 - $41.79 $8,957 - $10,363	-248 Reduced 3.35%	7,165 $263 Million
Q1 2023 Dec 05, 2023	BUY	$39.39 - $51.28 $9,768 - $12,717	248 Added 3.46%	7,413 $302 Million
Q3 2022 Dec 05, 2023	SELL	$43.76 - $53.42 $33,038 - $40,332	-755 Reduced 9.53%	7,165 $314 Million
Q2 2022 Dec 05, 2023	SELL	$46.53 - $55.17 $2,093 - $2,482	-45 Reduced 0.56%	7,920 $415 Million
Q1 2022 Dec 05, 2023	SELL	$45.75 - $56.69 $43,691 - $54,138	-955 Reduced 10.71%	7,965 $412 Million
Q4 2021 Dec 05, 2023	BUY	$41.32 - $61.25 $368,574 - $546,350	8,920 New	8,920 $527 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Morton Capital Management Llc/Ca, based on Form 13F filings with the SEC.

Stay updated on Morton Capital Management Llc/Ca with notifications on news.